The two applications relate to the use of two algal oils, which are both a source of omega-3 fatty acids and extracted from two different strains of Schizochytrium microalgae.
DSM has now applied to extend the use of the docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) rich algal oil, in accordance with Article 4 of Regulation (EC) 258/97.
The oils were initially evaluated for use in the EU as a novel food ingredient in 2011, and were confirmed for a range of uses in July 2012.
However DSM now wishes to extend the uses of the oils in order to align the authorised uses of the two oils, and use them in food supplements for doses of up to 3g per day - something that the UK competent authority has initially suggested will be possible.
“In view of the ACNFP's advice, the UK Competent Authority considers that this algal oil, at levels of up to 3000 mg EPA and DHA per day in food supplements, and not exceeding the maximum use levels previously described for other foods, meets the criteria for acceptance of a novel food defined in Article 3(1) of regulation 258/97,” states the FSA draft opinion.
The application notes that extending the use of both oils in this way will not lead to people consuming them at levels that are more than the European Food Safety Authority’s (EFSA’s) tolerable upper intake level of EPA and DHA of 5g per day.
Comments wanted
The ACNFP said that after considering the applications, it has formulated positive draft opinions.
The Authority is now inviting comments on the opinions (found here).
Any comments should be emailed to the ACNFP Secretariat at acnfp@foodstandards.gsi.gov.uk by Monday 22 April 2013. The comments received will be passed to the committee before it adopts its final opinions on the novel food ingredients.